Basswood Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Basswood Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-26,466	Closed	-$1.39M	–	176
2014 Q2	$1.39M	Sell	26,466 -10,472	-28%	-$535K	0.07%	147
2014 Q1	$1.95M	Sell	36,938 -19,045	-34%	-$880K	0.1%	142
2013 Q4	$2.24M	Sell	55,983 -47,521	-46%	-$1.87M	0.12%	123
2013 Q3	$3.91M	Sell	103,504 -724	-0.7%	-$28.2K	0.22%	108
2013 Q2	$4.08M	Buy	+104,228	New	+$4.06M	0.26%	105

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Basswood Capital Management's TEVA Position: Q3 2014 in Review

Basswood Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 26,466 shares — an estimated $1.39M sold.

Basswood Capital Management first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $4.08M in Q2 2013. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

Basswood Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Basswood Capital Management sold 26,466 Teva Pharmaceuticals shares in Q3 2014, an estimated $1.39M.
Basswood Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Basswood Capital Management's Teva Pharmaceuticals position peaked at $4.08M in Q2 2013.
773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Basswood Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.